1.0
24. Juni 2021
Aktueller Mitarbeiter, mehr als 3 Jahre
Plymouth Meeting, PA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Great co-workers who care about good science.
Kontras
Poor executive and scientific leadership has squandered the company's position as an industry leader in COVID vaccine research. Significant numbers of people jumping ship every month - legal and clinical operations department cannot keep up with the losses.